Diabetic Nephropathy News and Research

RSS
Diabetic nephropathy is kidney disease or damage that results as a complication of diabetes.
Urinary adiponectin as a marker for diabetic nephropathy

Urinary adiponectin as a marker for diabetic nephropathy

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

NOXXON commences NOX-A12 Phase IIa trial in relapsed MM

PCA inhibits multiple pathways involved in development of diabetic nephropathy

PCA inhibits multiple pathways involved in development of diabetic nephropathy

Age at diabetes onset linked to macular edema onset

Age at diabetes onset linked to macular edema onset

Sleep apnea’s contribution to diabetic nephropathy needs attention

Sleep apnea’s contribution to diabetic nephropathy needs attention

Biopsy required for accurate renal diagnosis in diabetes

Biopsy required for accurate renal diagnosis in diabetes

Low HDL cholesterol ADVANCEs nephropathy risk in diabetes

Low HDL cholesterol ADVANCEs nephropathy risk in diabetes

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Genkyotex closes CHF25M Series C extension

Genkyotex closes CHF25M Series C extension

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Bariatric surgery can remit or prevent diabetic nephropathy in obese patients

Bariatric surgery can remit or prevent diabetic nephropathy in obese patients

ChemoCentryx fourth quarter revenues increase to $26.1 million

ChemoCentryx fourth quarter revenues increase to $26.1 million

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Questcor fourth quarter net sales increase to $75.5 million

Questcor fourth quarter net sales increase to $75.5 million

New biomarkers can predict risk of kidney failure in patients with diabetes

New biomarkers can predict risk of kidney failure in patients with diabetes

Questcor reports record vial shipments of Acthar in fourth quarter 2011

Questcor reports record vial shipments of Acthar in fourth quarter 2011

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

JAMA commentary argues that vitamin therapy still plays a role in reducing stroke

JAMA commentary argues that vitamin therapy still plays a role in reducing stroke

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy